Smital Shah
Directeur/Bestuurslid bij PLIANT THERAPEUTICS, INC.
Vermogen: 12 978 $ op 30-04-2024
Actieve functies van Smital Shah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Directeur/Bestuurslid | 14-03-2019 | - |
| Independent Dir/Board Member | 14-03-2019 | - |
Loopbaan van Smital Shah
Eerdere bekende functies van Smital Shah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PROQR THERAPEUTICS N.V. | Financieel Directeur/CFO | 03-10-2014 | 01-10-2022 |
| Investor Relations Contact | 03-10-2014 | - | |
| GILEAD SCIENCES, INC. | Treasurer | 01-08-2012 | 01-09-2014 |
| LENZ THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-04-2021 | - |
| Independent Dir/Board Member | 01-04-2021 | - |
Opleiding van Smital Shah
| Virginia Polytechnic Institute & State University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Nederland | 2 |
| India | 2 |
Operationeel
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Smital Shah
- Ervaring
